ofloxacin has been researched along with mitomycin in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (25.00) | 18.7374 |
1990's | 1 (12.50) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 3 (37.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Nagai, A; Nagasawa, M; Nakamura, S; Nishio, Y; Nojima, Y; Yoneda, T | 1 |
Fay, M; Gougerot-Pocidalo, MA; Roche, Y | 1 |
Colston, MJ; Davis, EO; Keer, JT; Movahedzadeh, F; Papavinasasundaram, KG; Stoker, NG | 1 |
Azar, DT; Koch, JM; Melki, SA; Taneri, S | 1 |
Rischmann, P | 1 |
Fortier, LC; Meessen-Pinard, M; Sekulovic, O | 1 |
1 review(s) available for ofloxacin and mitomycin
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
7 other study(ies) available for ofloxacin and mitomycin
Article | Year |
---|---|
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding | 2012 |
[Toxicity studies on T-3262 in rat upon intravenous injection for 14 days].
Topics: Animals; Anti-Infective Agents; Body Weight; Bone Marrow; Drinking; Eating; Fluoroquinolones; Hematologic Tests; Injections, Intravenous; Kidney; Male; Mitomycin; Mitomycins; Naphthyridines; Ofloxacin; Organ Size; Rats; Rats, Inbred Strains | 1989 |
Enhancement of interleukin 2 production by quinolone-treated human mononuclear leukocytes.
Topics: Anti-Infective Agents; Ciprofloxacin; Humans; In Vitro Techniques; Interleukin-2; Kinetics; Leukocytes, Mononuclear; Lymphocyte Activation; Mitomycin; Mitomycins; Norfloxacin; Ofloxacin; Oxazines; Pefloxacin; Quinolines; Receptors, Immunologic; Receptors, Interleukin-2 | 1988 |
Mycobacterial recA is cotranscribed with a potential regulatory gene called recX.
Topics: Amino Acid Sequence; Bacterial Proteins; Base Sequence; Binding Sites; Chromosome Mapping; Cloning, Molecular; DNA Damage; Genes, Bacterial; Mitomycin; Molecular Sequence Data; Mycobacterium; Nucleic Acid Synthesis Inhibitors; Ofloxacin; Open Reading Frames; Operon; Peptide Chain Initiation, Translational; Protein Binding; Rec A Recombinases; Regulatory Sequences, Nucleic Acid; Sequence Analysis, DNA; Sequence Homology, Amino Acid; Serine Endopeptidases; Transcription, Genetic | 1997 |
Mitomycin-C assisted photorefractive keratectomy in the treatment of buttonholed laser in situ keratomileusis flaps associated with epithelial ingrowth.
Topics: Adult; Anti-Bacterial Agents; Cicatrix; Cornea; Corneal Diseases; Corneal Surgery, Laser; Drug Therapy, Combination; Epithelium, Corneal; Female; Humans; Keratomileusis, Laser In Situ; Mitomycin; Nucleic Acid Synthesis Inhibitors; Ofloxacin; Prednisolone; Surgical Flaps | 2005 |
[ BCG-immunotherapy and bladder cancer].
Topics: Adjuvants, Immunologic; Administration, Intravesical; Anti-Bacterial Agents; Antibiotics, Antineoplastic; BCG Vaccine; Cystectomy; Humans; Mitomycin; Ofloxacin; Prognosis; Randomized Controlled Trials as Topic; Risk Factors; Time Factors; Urinary Bladder Neoplasms | 2008 |
Evidence of in vivo prophage induction during Clostridium difficile infection.
Topics: Anti-Bacterial Agents; Aza Compounds; Base Sequence; Ciprofloxacin; Clostridioides difficile; Clostridium Infections; DNA, Viral; Feces; Fluoroquinolones; Genetic Variation; Genome, Viral; Humans; Levofloxacin; Lysogeny; Microbial Sensitivity Tests; Mitomycin; Molecular Sequence Data; Moxifloxacin; Myoviridae; Ofloxacin; Prophages; Quinolines; Sequence Analysis, DNA; Virus Activation | 2012 |